Back to search
FDAFDA · Food and drugs·Recall number D-0075-2021

Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77

Published November 11, 2020 · Recall initiated: October 27, 2020

Summary

FDA records drug Class II recall D-0075-2021, published November 11, 2020 and initiated October 27, 2020. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Terminated; Reported quantity: 7,908 units; Lot: Lot # M005682, EXP 3/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification

What to do

Voluntary: Firm initiated · Letter

Get an email if LANSOPRAZOLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LANSOPRAZOLE
Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
Distributed Nationwide in the USA
Lot
Lot # M005682, EXP 3/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77 recalled?

Yes. FDA published recall D-0075-2021 on November 11, 2020. Reported hazard: Failed Dissolution Specification

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LANSOPRAZOLE.